alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › recognition

recognition

2 studies tagged recognition, dated 2017-09-18 to 2018-07-24. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Designed Macrocyclic Peptides as Nanomolar Amyloid Inhibitors Based on Minimal Recognition Elements 2018-07-24
  2. Mechanisms of recognition of amyloid-β (Aβ) monomer, oligomer, and fibril by homologous antibodies 2017-09-18

Studies

2 studies carry this tag.

Date range

2017 to 2018

Top journals

  • Angewandte Chemie (International ed. in English) 1
  • The Journal of biological chemistry 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Designed Macrocyclic Peptides as Nanomolar Amyloid Inhibitors Based on Minimal Recognition Elements

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Angewandte Chemie (International ed. in English) 2018-07-24 Treatments

    Amyloid self-assembly is linked to the pathogenesis of Alzheimer's disease (AD) and type 2 diabetes (T2D), but so far, no anti-amyloid compound has reached the clinic.

  2. Mechanisms of recognition of amyloid-β (Aβ) monomer, oligomer, and fibril by homologous antibodies

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. The Journal of biological chemistry 2017-09-18 Treatments

    Alzheimer's disease is one of the most devastating neurodegenerative diseases without effective therapies.

All topic tags with their study counts